Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fenavari
- Development stage
- Unknown
- Lead developer
- OmniActive Health Technologies
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Fenavari is a proprietary botanical ingredient developed by OmniActive Health Technologies to support women experiencing perimenopause, menopause, and postmenopause. It is a standardized, plant-based combination of fenugreek (Trigonella foenum-graecum) and shatavari (Asparagus racemosus) extracts, produced using green solvents and OmniActive's proprietary Integrated Actives technology. Standardized to 6% shatavarin IV and 4% protodioscin, Fenavari acts through phytoestrogenic, adaptogenic, and antioxidant pathways to address menopausal symptoms such as hot flashes, night sweats, sleep disturbances, mood changes, anxiety, and sexual wellness. Clinical studies demonstrate that Fenavari supports healthy hormonal balance by modulating estradiol and follicle-stimulating hormone (FSH) levels, as well as serum dopamine and brain-derived neurotrophic factor (BDNF) expression.
- Brand names
- Fenavari
- Other names
- Asparagus racemosus extract + Trigonella foenum-graecum extractfenugreek extract + shatavari extract
02
Targets
ER (Estrogen receptor)
Beyond the preview
Go deeper on Fenavari.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fenavari.